The company noted that GAAP EPS includes special items (Attachment 3) primarily associated with acquisition-related costs and an adjustment to environmental reserves. Acquisition-related costs primarily consist of inventory step-up and the financing commitment for the Clariant Masterbatch acquisition. Adjusted EPS of
"I am pleased with our results for the quarter given the recent challenges of the coronavirus pandemic. As we closed out September, we experienced better-than-expected revenue and margin performance across all businesses and regions," said
The company noted that integration with the Clariant Masterbatch business continues to exceed expectations and confirmed its recently increased synergy estimate of
"As we start the fourth quarter, we see demand continuing to improve but recognize there remains uncertainty with how the ongoing pandemic recovery will unfold,"
New Sustainability Report and 2030 Sustainability Goals
Sustainable solutions remain a key driver of growth for the company, and the most recent contributions and data are available in
Conference Call
A recording of the call will also be available for one week, beginning at
About
Forward-looking Statements
In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. They use words such as "will," "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include the impact the COVID-19 pandemic has on our business, results from operations, financial condition and liquidity; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's Masterbatch business and achieve the expected results of the acquisition of Clariant's Masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to continue to pay cash dividends including at the increased rate; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation. The above list of factors is not exhaustive.
We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the
Attachment 1 |
|||||||||||||||
Avient Corporation |
|||||||||||||||
Summary of Condensed Consolidated Statements of Income (Unaudited) |
|||||||||||||||
(In millions, except per share data) |
|||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||
2020 |
2019 |
2020 |
2019 |
||||||||||||
Sales |
$ |
924.5 |
$ |
705.3 |
$ |
2,245.1 |
$ |
2,204.1 |
|||||||
Operating Income |
33.5 |
43.1 |
124.3 |
136.3 |
|||||||||||
Net income from continuing operations attributable to |
1.7 |
23.5 |
57.8 |
69.1 |
|||||||||||
Basic earnings per share from continuing operations attributable to |
$ |
0.02 |
$ |
0.31 |
$ |
0.64 |
$ |
0.89 |
|||||||
Diluted earnings per share from continuing operations attributable to |
$ |
0.02 |
$ |
0.30 |
$ |
0.64 |
$ |
0.89 |
Senior management uses comparisons of adjusted net income from continuing operations attributable to
Three Months Ended |
Three Months Ended |
||||||||||||||
Reconciliation to Condensed Consolidated Statements of Income |
$ |
EPS |
$ |
EPS |
|||||||||||
Net income from continuing operations attributable to |
$ |
1.7 |
$ |
0.02 |
$ |
23.5 |
$ |
0.30 |
|||||||
Special items, after tax (Attachment 3) |
40.3 |
0.44 |
10.5 |
0.14 |
|||||||||||
Adjusted net income / EPS - excluding special items |
$ |
42.0 |
$ |
0.46 |
$ |
34.0 |
$ |
0.44 |
Nine Months Ended |
Nine Months Ended |
||||||||||||||
Reconciliation to Condensed Consolidated Statements of Income |
$ |
EPS |
$ |
EPS |
|||||||||||
Net income from continuing operations attributable to |
$ |
57.8 |
$ |
0.64 |
$ |
69.1 |
$ |
0.89 |
|||||||
Special items, after tax (Attachment 3) |
51.5 |
0.57 |
35.9 |
0.46 |
|||||||||||
Adjusted net income / EPS - excluding special items |
$ |
109.3 |
$ |
1.21 |
$ |
105.0 |
$ |
1.35 |
For purposes of comparability to the prior year, senior management has referenced adjusted EPS excluding special items and the impact of the Clariant Masterbatch (MB) step-up depreciation and amortization. This calculation of adjusted EPS excludes the additional step-up in depreciation recognized in connection with the Clariant MB acquisition.
Three Months Ended |
Three Months Ended |
||||||||||||||
Reconciliation to Condensed Consolidated Statements of Income |
$ |
EPS |
$ |
EPS |
|||||||||||
Net income from continuing operations attributable to |
$ |
1.7 |
$ |
0.02 |
$ |
23.5 |
$ |
0.30 |
|||||||
Special items and the impact of Clariant MB step-up depreciation and amortization, after tax (Attachment 7) |
47.5 |
0.52 |
10.5 |
0.14 |
|||||||||||
Adjusted net income / EPS - excluding special items and Clariant MB step-up depreciation and amortization |
$ |
49.2 |
$ |
0.54 |
$ |
34.0 |
$ |
0.44 |
Nine Months Ended |
Nine Months Ended |
||||||||||||||
Reconciliation to Condensed Consolidated Statements of Income |
$ |
EPS |
$ |
EPS |
|||||||||||
Net income from continuing operations attributable to |
$ |
57.8 |
$ |
0.64 |
$ |
69.1 |
$ |
0.89 |
|||||||
Special items and the impact of Clariant MB step-up depreciation and amortization, after tax (Attachment 7) |
58.7 |
0.65 |
35.9 |
0.46 |
|||||||||||
Adjusted net income / EPS - excluding special items and Clariant MB step-up depreciation and amortization |
$ |
116.5 |
$ |
1.29 |
$ |
105.0 |
$ |
1.35 |
Attachment 2 |
|||||||||||||||
|
|||||||||||||||
Condensed Consolidated Statements of Income (Unaudited) |
|||||||||||||||
(In millions, except per share data) |
|||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||
2020 |
2019 |
2020 |
2019 |
||||||||||||
Sales |
$ |
924.5 |
$ |
705.3 |
$ |
2,245.1 |
$ |
2,204.1 |
|||||||
Cost of sales |
714.3 |
544.8 |
1,713.7 |
1,700.2 |
|||||||||||
Gross margin |
210.2 |
160.5 |
531.4 |
503.9 |
|||||||||||
Selling and administrative expense |
176.7 |
117.4 |
407.1 |
367.6 |
|||||||||||
Operating income |
33.5 |
43.1 |
124.3 |
136.3 |
|||||||||||
Interest expense, net |
(29.7) |
(15.5) |
(55.3) |
(47.6) |
|||||||||||
Other income, net |
1.5 |
0.6 |
12.6 |
1.4 |
|||||||||||
Income from continuing operations before income taxes |
5.3 |
28.2 |
81.6 |
90.1 |
|||||||||||
Income taxes |
(2.7) |
(4.6) |
(22.5) |
(20.8) |
|||||||||||
Net income from continuing operations |
2.6 |
23.6 |
59.1 |
69.3 |
|||||||||||
Income (loss) from discontinued operations, net of income taxes |
— |
19.5 |
(0.5) |
54.2 |
|||||||||||
Net income |
2.6 |
43.1 |
58.6 |
123.5 |
|||||||||||
Net income attributable to noncontrolling interests |
(0.9) |
(0.1) |
(1.3) |
(0.2) |
|||||||||||
Net income attributable to |
$ |
1.7 |
$ |
43.0 |
$ |
57.3 |
$ |
123.3 |
|||||||
Earnings per share attributable to |
|||||||||||||||
Continuing operations |
$ |
0.02 |
$ |
0.31 |
$ |
0.64 |
$ |
0.89 |
|||||||
Discontinued operations |
— |
0.25 |
— |
0.71 |
|||||||||||
Total |
$ |
0.02 |
$ |
0.56 |
$ |
0.64 |
$ |
1.60 |
|||||||
Earnings per share attributable to |
|||||||||||||||
Continuing operations |
$ |
0.02 |
$ |
0.30 |
$ |
0.64 |
$ |
0.89 |
|||||||
Discontinued operations |
— |
0.26 |
(0.01) |
0.69 |
|||||||||||
Total |
$ |
0.02 |
$ |
0.56 |
$ |
0.63 |
$ |
1.58 |
|||||||
Cash dividends declared per share of common stock |
$ |
0.2025 |
$ |
0.1950 |
$ |
0.6075 |
$ |
0.5850 |
|||||||
Weighted-average shares used to compute earnings per common share: |
|||||||||||||||
Basic |
91.5 |
76.9 |
89.7 |
77.3 |
|||||||||||
Diluted |
91.9 |
77.4 |
90.7 |
77.8 |
Attachment 3 |
|||||||||||||||
|
|||||||||||||||
Summary of Special Items (Unaudited) |
|||||||||||||||
(In millions, except per share data) |
|||||||||||||||
Special items (1) |
Three Months Ended |
Nine Months Ended |
|||||||||||||
2020 |
2019 |
2020 |
2019 |
||||||||||||
Cost of sales: |
|||||||||||||||
Restructuring costs, including accelerated depreciation and amortization |
$ |
(1.3) |
$ |
— |
$ |
(2.5) |
$ |
0.3 |
|||||||
Environmental remediation costs |
(15.8) |
(6.4) |
(19.3) |
(10.4) |
|||||||||||
Reimbursement of previously incurred environmental costs |
— |
4.0 |
8.7 |
4.0 |
|||||||||||
Inventory fair market value step-up expense |
(10.5) |
— |
(10.5) |
(2.0) |
|||||||||||
Impact on cost of sales |
(27.6) |
(2.4) |
(23.6) |
(8.1) |
|||||||||||
Selling and administrative expense: |
|||||||||||||||
Restructuring, legal and other |
(6.9) |
(3.0) |
(15.3) |
(15.0) |
|||||||||||
Acquisition earn-out adjustments |
(1.5) |
(10.0) |
(2.5) |
(20.7) |
|||||||||||
Acquisition related costs |
(4.4) |
(1.0) |
(17.7) |
(3.3) |
|||||||||||
Impact on selling and administrative expense |
(12.8) |
(14.0) |
(35.5) |
(39.0) |
|||||||||||
Impact on operating income |
(40.4) |
(16.4) |
(59.1) |
(47.1) |
|||||||||||
Costs related to committed financing in interest expense, net |
(9.6) |
— |
(10.1) |
— |
|||||||||||
Other income, net |
— |
0.1 |
0.3 |
0.4 |
|||||||||||
Pension settlement gain and mark-to-market adjustment |
— |
— |
6.9 |
— |
|||||||||||
Impact on income from continuing operations before income taxes |
(50.0) |
(16.3) |
(62.0) |
(46.7) |
|||||||||||
Income tax benefit on above special items |
12.7 |
4.1 |
15.4 |
11.5 |
|||||||||||
Tax adjustments(2) |
(3.0) |
1.7 |
(4.9) |
(0.7) |
|||||||||||
Impact of special items on net income from continuing operations attributable to Avient Shareholders |
$ |
(40.3) |
$ |
(10.5) |
$ |
(51.5) |
$ |
(35.9) |
|||||||
Diluted earnings per common share impact, excluding Clariant MB step-up depreciation and amortization |
$ |
(0.44) |
$ |
(0.14) |
$ |
(0.57) |
$ |
(0.46) |
|||||||
Weighted average shares used to compute adjusted earnings per share: |
|||||||||||||||
Diluted |
91.9 |
77.4 |
90.7 |
77.8 |
(1) |
Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results. |
(2) |
Tax adjustments include the net tax benefit/(expense) from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments. |
Attachment 4 |
|||||||
|
|||||||
Condensed Consolidated Balance Sheets |
|||||||
(In millions) |
|||||||
(Unaudited) |
2019 |
||||||
ASSETS |
|||||||
Current assets: |
|||||||
Cash and cash equivalents |
$ |
577.3 |
$ |
864.7 |
|||
Accounts receivable, net |
514.3 |
330.0 |
|||||
Inventories, net |
311.4 |
260.9 |
|||||
Other current assets |
94.8 |
57.7 |
|||||
Total current assets |
1,497.8 |
1,513.3 |
|||||
Property, net |
674.5 |
407.4 |
|||||
|
1,280.0 |
685.7 |
|||||
Intangible assets, net |
993.0 |
469.3 |
|||||
Operating lease assets, net |
88.3 |
63.8 |
|||||
Other non-current assets |
176.3 |
133.8 |
|||||
Total assets |
$ |
4,709.9 |
$ |
3,273.3 |
|||
LIABILITIES AND SHAREHOLDERS' EQUITY |
|||||||
Current liabilities: |
|||||||
Short-term and current portion of long-term debt |
$ |
18.7 |
$ |
18.4 |
|||
Accounts payable |
403.6 |
287.7 |
|||||
Current operating lease obligations |
25.3 |
21.0 |
|||||
Accrued expenses and other current liabilities |
321.3 |
375.4 |
|||||
Total current liabilities |
768.9 |
702.5 |
|||||
Non-current liabilities: |
|||||||
Long-term debt |
1,855.2 |
1,210.9 |
|||||
Pension and other post-retirement benefits |
113.8 |
56.6 |
|||||
Non-current operating lease obligations |
63.0 |
42.8 |
|||||
Other non-current liabilities |
297.9 |
207.8 |
|||||
Total non-current liabilities |
2,329.9 |
1,518.1 |
|||||
SHAREHOLDERS' EQUITY |
|||||||
|
1,597.0 |
1,051.9 |
|||||
Noncontrolling interest |
14.1 |
0.8 |
|||||
Total equity |
1,611.1 |
1,052.7 |
|||||
Total liabilities and equity |
$ |
4,709.9 |
$ |
3,273.3 |
Attachment 5 |
|||||||
|
|||||||
Condensed Consolidated Statements of Cash Flows (Unaudited) |
|||||||
(In millions) |
|||||||
Nine Months Ended |
|||||||
2020 |
2019 |
||||||
Operating Activities |
|||||||
Net income |
$ |
58.6 |
$ |
123.5 |
|||
Adjustments to reconcile net income to net cash provided by operating activities: |
|||||||
Depreciation and amortization |
74.8 |
68.4 |
|||||
Accelerated depreciation and amortization |
2.5 |
— |
|||||
Share-based compensation expense |
7.1 |
8.7 |
|||||
Changes in assets and liabilities, net of the effect of acquisitions: |
|||||||
Increase in accounts receivable |
(12.7) |
(12.7) |
|||||
Decrease in inventories |
53.0 |
20.0 |
|||||
Increase (decrease) in accounts payable |
21.3 |
(28.3) |
|||||
Decrease in pension and other post-retirement benefits |
(14.4) |
(7.0) |
|||||
Increase in post-acquisition earnout liabilities |
2.5 |
20.7 |
|||||
Increase in accrued expenses and other assets and liabilities, net |
56.1 |
5.3 |
|||||
Taxes paid on gain on divestiture |
(142.0) |
— |
|||||
Payment of post-acquisition date earnout liability |
(38.1) |
— |
|||||
Net cash provided by operating activities |
68.7 |
198.6 |
|||||
Investing activities |
|||||||
Capital expenditures |
(38.6) |
(47.9) |
|||||
Business acquisitions, net of cash acquired |
(1,342.7) |
(119.6) |
|||||
Net proceeds from divestiture |
7.1 |
— |
|||||
Net proceeds from other assets |
5.2 |
5.3 |
|||||
Net cash used by investing activities |
(1,369.0) |
(162.2) |
|||||
Financing activities |
|||||||
Debt offering proceeds |
650.0 |
— |
|||||
Borrowings under credit facilities |
— |
882.4 |
|||||
Repayments under credit facilities |
— |
(808.5) |
|||||
Purchase of common shares for treasury |
(13.6) |
(26.9) |
|||||
Cash dividends paid |
(52.8) |
(45.7) |
|||||
Repayment of long-term debt |
(6.0) |
(4.9) |
|||||
Payments of withholding tax on share awards |
(1.9) |
(2.0) |
|||||
Debt financing costs |
(9.5) |
(0.2) |
|||||
Equity offering proceeds, net of underwriting discount and issuance costs |
496.1 |
— |
|||||
Payment of acquisition date earnout liability |
(50.8) |
— |
|||||
Net cash provided (used) by financing activities |
1,011.5 |
(5.8) |
|||||
Effect of exchange rate changes on cash |
1.4 |
(1.9) |
|||||
(Decrease) increase in cash and cash equivalents |
(287.4) |
28.7 |
|||||
Cash and cash equivalents at beginning of year |
864.7 |
170.9 |
|||||
Cash and cash equivalents at end of period |
$ |
577.3 |
$ |
199.6 |
Attachment 6 |
|||||||||||||||
|
|||||||||||||||
Business Segment Operations (Unaudited) |
|||||||||||||||
(In millions) |
|||||||||||||||
Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker. These costs are included in Corporate and eliminations. |
|||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||
2020 |
2019 |
2020 |
2019 |
||||||||||||
Sales: |
|||||||||||||||
Color, Additives and Inks |
$ |
493.8 |
$ |
246.3 |
$ |
977.1 |
$ |
777.1 |
|||||||
Specialty Engineered Materials |
174.1 |
183.0 |
518.2 |
568.2 |
|||||||||||
Distribution |
276.9 |
295.9 |
805.2 |
919.8 |
|||||||||||
Corporate and eliminations |
(20.3) |
(19.9) |
(55.4) |
(61.0) |
|||||||||||
Sales |
$ |
924.5 |
$ |
705.3 |
$ |
2,245.1 |
$ |
2,204.1 |
|||||||
Gross margin: |
|||||||||||||||
Color, Additives and Inks |
$ |
155.0 |
$ |
83.7 |
$ |
320.1 |
$ |
264.5 |
|||||||
Specialty Engineered Materials |
53.4 |
48.1 |
148.5 |
152.5 |
|||||||||||
Distribution |
30.8 |
32.7 |
91.6 |
101.1 |
|||||||||||
Corporate and eliminations |
(29.0) |
(4.0) |
(28.8) |
(14.2) |
|||||||||||
Gross margin |
$ |
210.2 |
$ |
160.5 |
$ |
531.4 |
$ |
503.9 |
|||||||
Selling and administrative expense: |
|||||||||||||||
Color, Additives and Inks |
$ |
104.5 |
$ |
45.3 |
$ |
196.8 |
$ |
144.3 |
|||||||
Specialty Engineered Materials |
28.7 |
28.6 |
84.5 |
87.6 |
|||||||||||
Distribution |
13.3 |
13.9 |
40.1 |
42.7 |
|||||||||||
Corporate and eliminations |
30.2 |
29.6 |
85.7 |
93.0 |
|||||||||||
Selling and administrative expense |
$ |
176.7 |
$ |
117.4 |
$ |
407.1 |
$ |
367.6 |
|||||||
Operating income: |
|||||||||||||||
Color, Additives and Inks |
$ |
50.5 |
$ |
38.4 |
$ |
123.3 |
$ |
120.2 |
|||||||
Specialty Engineered Materials |
24.7 |
19.5 |
64.0 |
64.9 |
|||||||||||
Distribution |
17.5 |
18.8 |
51.5 |
58.4 |
|||||||||||
Corporate and eliminations |
(59.2) |
(33.6) |
(114.5) |
(107.2) |
|||||||||||
Operating income |
$ |
33.5 |
$ |
43.1 |
$ |
124.3 |
$ |
136.3 |
|||||||
Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA): |
|||||||||||||||
Color, Additives and Inks |
$ |
76.8 |
$ |
49.2 |
$ |
171.3 |
$ |
152.5 |
|||||||
Specialty Engineered Materials |
32.2 |
27.2 |
86.7 |
87.7 |
|||||||||||
Distribution |
17.7 |
18.9 |
51.9 |
58.8 |
|||||||||||
Corporate and eliminations |
(55.2) |
(31.9) |
(95.7) |
(102.3) |
|||||||||||
EBITDA |
$ |
71.5 |
$ |
63.4 |
$ |
214.2 |
$ |
196.7 |
Attachment 7 |
|||||||||||||||
|
|||||||||||||||
Reconciliation of Non-GAAP Financial Measures (Unaudited) |
|||||||||||||||
(In millions, except per share data) |
|||||||||||||||
Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance. In addition, operating income before the effect of special items is a component of |
|||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||
Reconciliation to Consolidated Statements of Income |
2020 |
2019 |
2020 |
2019 |
|||||||||||
Sales |
$ |
924.5 |
$ |
705.3 |
$ |
2,245.1 |
$ |
2,204.1 |
|||||||
Gross margin - GAAP |
210.2 |
160.5 |
531.4 |
503.9 |
|||||||||||
Special items in gross margin (Attachment 3) |
27.6 |
2.4 |
23.6 |
8.1 |
|||||||||||
Adjusted Gross margin |
$ |
237.8 |
$ |
162.9 |
$ |
555.0 |
$ |
512.0 |
|||||||
Adjusted Gross margin as a percent of sales |
25.7 |
% |
23.1 |
% |
24.7 |
% |
23.2 |
% |
|||||||
Operating income - GAAP |
33.5 |
43.1 |
124.3 |
136.3 |
|||||||||||
Special items in operating income (Attachment 3) |
40.4 |
16.4 |
59.1 |
47.1 |
|||||||||||
Adjusted Operating income |
$ |
73.9 |
$ |
59.5 |
$ |
183.4 |
$ |
183.4 |
|||||||
Adjusted Operating income as a percent of sales |
8.0 |
% |
8.4 |
% |
8.2 |
% |
8.3 |
% |
The table below reconciles pre-special income tax expense and the pre-special effective tax rate to their most comparable US GAAP figures.
Three Months Ended |
Three Months Ended |
||||||||||||||||||||||
GAAP |
Special |
Adjusted |
GAAP |
Special |
Adjusted |
||||||||||||||||||
Income from continuing operations before income taxes |
$ |
5.3 |
$ |
50.0 |
$ |
55.3 |
$ |
28.2 |
$ |
16.3 |
$ |
44.5 |
|||||||||||
Income tax expense - GAAP |
(2.7) |
— |
(2.7) |
(4.6) |
— |
(4.6) |
|||||||||||||||||
Income tax impact of special items (Attachment 3) |
— |
(12.7) |
(12.7) |
— |
(4.1) |
(4.1) |
|||||||||||||||||
Tax adjustments (Attachment 3) |
— |
3.0 |
3.0 |
— |
(1.7) |
(1.7) |
|||||||||||||||||
Income tax (expense) benefit |
$ |
(2.7) |
$ |
(9.7) |
$ |
(12.4) |
$ |
(4.6) |
$ |
(5.8) |
$ |
(10.4) |
|||||||||||
Effective Tax Rate(1) |
51.9 |
% |
22.7 |
% |
16.4 |
% |
23.5 |
% |
Nine Months Ended |
Nine Months Ended |
||||||||||||||||||||||
GAAP |
Special |
Adjusted |
GAAP |
Special |
Adjusted |
||||||||||||||||||
Income from continuing operations before income taxes |
$ |
81.6 |
$ |
62.0 |
$ |
143.6 |
$ |
90.1 |
$ |
46.7 |
$ |
136.8 |
|||||||||||
Income tax expense - GAAP |
(22.5) |
— |
(22.5) |
(20.8) |
— |
(20.8) |
|||||||||||||||||
Income tax impact of special items (Attachment 3) |
— |
(15.4) |
(15.4) |
— |
(11.5) |
(11.5) |
|||||||||||||||||
Tax adjustments (Attachment 3) |
— |
4.9 |
4.9 |
— |
0.7 |
0.7 |
|||||||||||||||||
Income tax expense |
$ |
(22.5) |
$ |
(10.5) |
$ |
(33.0) |
$ |
(20.8) |
$ |
(10.8) |
$ |
(31.6) |
|||||||||||
Effective Tax Rate(1) |
27.6 |
% |
23.0 |
% |
23.1 |
% |
23.2 |
% |
(1) |
Rate may not recalculate from figures presented herein due to rounding. |
We also monitor earnings (defined as net income from continuing operations) before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA (EBITDA before the impact of special items) as a supplement to our GAAP measures. EBITDA and Adjusted EBITDA are non-GAAP financial measures that management uses in evaluating operating performance. The presentation of these measures is not intended to be considered in isolation from, as a substitute for, or as superior to, the financial information prepared and presented in accordance with
Reconciliation to Adjusted EBITDA |
Three Months Ended |
Three Months Ended |
||||
Net income from continuing operations – GAAP |
$ |
2.6 |
$ |
23.6 |
||
Income tax expense |
2.7 |
4.6 |
||||
Interest expense |
29.7 |
15.5 |
||||
Depreciation and amortization from continuing operations |
36.5 |
19.7 |
||||
EBITDA |
71.5 |
63.4 |
||||
Special items, before tax (Attachment 3) |
50.0 |
16.3 |
||||
Interest expense included in special items (Attachment 3) |
(9.6) |
— |
||||
Accelerated depreciation included in special items (Attachment 3) |
(1.3) |
— |
||||
Adjusted EBITDA |
$ |
110.6 |
$ |
79.7 |
Reconciliation to Adjusted EBITDA |
Nine Months Ended |
Nine Months Ended |
||||
Net income from continuing operations – GAAP |
$ |
59.1 |
$ |
69.3 |
||
Income tax expense |
22.5 |
20.8 |
||||
Interest expense |
55.3 |
47.6 |
||||
Depreciation and amortization from continuing operations |
77.3 |
59.0 |
||||
EBITDA |
214.2 |
196.7 |
||||
Special items, before tax (Attachment 3) |
62.0 |
46.7 |
||||
Interest expense included in special items (Attachment 3) |
(10.1) |
— |
||||
Accelerated depreciation included in special items (Attachment 3) |
(2.5) |
— |
||||
Adjusted EBITDA |
$ |
263.6 |
$ |
243.4 |
Reconciliation of EBITDA by Segment |
Three Months Ended |
Nine Months Ended |
|||||||||||||
2020 |
2019 |
2020 |
2019 |
||||||||||||
Operating income: |
|||||||||||||||
Color, Additives and Inks |
$ |
50.5 |
$ |
38.4 |
$ |
123.3 |
$ |
120.2 |
|||||||
Specialty Engineered Materials |
24.7 |
19.5 |
64.0 |
64.9 |
|||||||||||
Distribution |
17.5 |
18.8 |
51.5 |
58.4 |
|||||||||||
Corporate and eliminations |
(59.2) |
(33.6) |
(114.5) |
(107.2) |
|||||||||||
Operating income |
$ |
33.5 |
$ |
43.1 |
$ |
124.3 |
$ |
136.3 |
|||||||
Items Below OI in Corporate |
|||||||||||||||
Other income, net |
$ |
1.5 |
$ |
0.6 |
$ |
12.6 |
$ |
1.4 |
|||||||
Depreciation & Amortization: |
|||||||||||||||
Color, Additives and Inks |
$ |
26.3 |
$ |
10.8 |
$ |
48.0 |
$ |
32.3 |
|||||||
Specialty Engineered Materials |
7.5 |
7.7 |
22.7 |
22.8 |
|||||||||||
Distribution |
0.2 |
0.1 |
0.4 |
0.4 |
|||||||||||
Corporate and eliminations |
2.5 |
1.1 |
6.2 |
3.5 |
|||||||||||
Depreciation & Amortization |
$ |
36.5 |
$ |
19.7 |
$ |
77.3 |
$ |
59.0 |
|||||||
EBITDA |
|||||||||||||||
Color, Additives and Inks |
$ |
76.8 |
$ |
49.2 |
$ |
171.3 |
$ |
152.5 |
|||||||
Specialty Engineered Materials |
32.2 |
27.2 |
86.7 |
87.7 |
|||||||||||
Distribution |
17.7 |
18.9 |
51.9 |
58.8 |
|||||||||||
Corporate and eliminations |
(55.2) |
(31.9) |
(95.7) |
(102.3) |
|||||||||||
EBITDA |
$ |
71.5 |
$ |
63.4 |
$ |
214.2 |
$ |
196.7 |
Free cash flow, defined as cash provided by operating activities excluding items associated with acquisitions and divestitures, less capital expenditures, is considered a non-GAAP financial measure. Management believes, however, that free cash flow, which measures our ability to generate additional cash from our business operations, is an important financial measure for use in evaluating the company's financial performance. Free cash flow should be considered in addition to, rather than as a substitute for, consolidated net income as a measure of our performance and net cash provided by operating activities as a measure of our liquidity.
Free Cash Flow Calculation |
Three Months Ended |
||
Cash used by operating activities |
$ |
(7.3) |
|
Capital expenditures |
(17.3) |
||
Free Cash Flow |
(24.6) |
||
Payment of post-acquisition date earnout liability |
17.1 |
||
Taxes paid on gain on sale of PP&S divestiture |
138.7 |
||
Net effect of timing items related to Clariant MB |
(24.3) |
||
Adjusted Free Cash Flow |
$ |
106.9 |
Three Months Ended |
|||||||||
Free Cash Flow Calculation |
Continuing |
Discontinued Operations |
Total |
||||||
Cash provided by operating activities |
$ |
70.1 |
$ |
29.1 |
$ |
99.2 |
|||
Capital expenditures |
17.5 |
3.9 |
21.4 |
||||||
Free Cash Flow |
$ |
52.6 |
$ |
25.2 |
$ |
77.8 |
Reconciliation to Adjusted net income / EPS - Excluding Special Items and Clariant MB Step-up Depreciation and Amortization |
Three Months Ended |
Nine Months Ended |
|||||||||||||
2020 |
2019 |
2020 |
2019 |
||||||||||||
Impact of special items on net income from continuing operations attributable to Avient Shareholders |
$ |
(40.3) |
$ |
(10.5) |
$ |
(51.5) |
$ |
(35.9) |
|||||||
Clariant MB step-up depreciation and amortization, net of tax |
(7.2) |
— |
(7.2) |
— |
|||||||||||
Impact of special items on net income from continuing operations attributable to Avient Shareholders and Clariant MB step-up depreciation & amortization |
(47.5) |
(10.5) |
(58.7) |
(35.9) |
|||||||||||
Diluted earnings per common share impact, including Clariant MB step-up depreciation and amortization |
$ |
(0.52) |
$ |
(0.14) |
$ |
(0.65) |
$ |
(0.46) |
|||||||
Weighted average shares used to compute adjusted earnings per share: |
|||||||||||||||
Diluted |
91.9 |
77.4 |
90.7 |
77.8 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/avient-announces-third-quarter-2020-results-301165682.html
SOURCE
Investor Relations Contact: Joe Di Salvo, Vice President, Treasurer and Investor Relations, Avient Corporation, +1 440-930-1921, giuseppe.disalvo@avient.com; Media Contact: Kyle G. Rose, Vice President, Corporate Communications, Avient Corporation, +1 440-930-3162, kyle.rose@avient.com